Join
Live feed
·
INSIDERFilingvia Quantisnow
NeuBase Therapeutics Inc. logo

SEC Form 4: Symetryx Corp sold $336,731 worth of shares (207,075 units at $1.63), decreasing direct ownership by 30% to 472,926 units

ByQuantisnow·Wall Street's wire, on your screen.
NBSE· NeuBase Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBSE (NeuBase Therapeutics Inc.) and more on Quantisnow.